Supplementary Figure S7 from A Model of Intratumor and Interpatient Heterogeneity Explains Clinical Trials of Curative Combination Therapy for Lymphoma
Year: 2025
Type: supplementary-materials
Abstract: Calibration to trials of pola-vedotin in R/R DLBCL and original POLARIX prediction
Authors: Amy E. Pomeroy, Adam C. Palmer
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4410099489